NCT00091871
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Hypereosinophilic Syndrome
Explore clinical trials studying Hypereosinophilic Syndrome. Study availability and eligibility vary by location and protocol.
31 public trials
8 recruiting studies
Hypereosinophilic Syndrome trial results
NCT06477653
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT04018118
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- Hôpital Roger Salengro, CHU Lille, France
Recruiting
Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
NCT03801434
- Conditions
- BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, +17 more
- Locations
-
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
- University of Utah Salt Lake City, Utah, United States
- Fred Hutchinson cancer research center Seattle, Washington, United States
NCT07275190
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +18 more
- Locations
-
- Fondazione IRCCS Policlinico San Matteo, SC Reumatologia Pavia, Italy
NCT05334368
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site Atlanta, Georgia, United States
- GSK Investigational Site Boston, Massachusetts, United States
- GSK Investigational Site Southfield, Michigan, United States
NCT02760238
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +34 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT04538937
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +24 more
- Locations
-
- University Clinic for Internal Medicine II Innsbruck, Austria
Not Yet Recruiting
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
NCT07444567
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Asthma, Autoimmune Diseases, +26 more
- Locations
-
Not specified
Not Yet Recruiting
Eosinophil Subpopulations in Eosinophilic-associated Diseases
NCT06911775
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +22 more
- Locations
-
Not specified